iSpecimen (NASDAQ:ISPC) Stock Price Up 2.6%

iSpecimen Inc. (NASDAQ:ISPC) shares rose 2.6% during trading on Monday . The company traded as high as $0.60 and last traded at $0.58. Approximately 290,954 shares traded hands during mid-day trading, an increase of 910% from the average daily volume of 28,794 shares. The stock had previously closed at $0.57.

iSpecimen Price Performance

The stock has a market capitalization of $5.26 million, a price-to-earnings ratio of -0.51 and a beta of 2.13. The firm’s fifty day moving average is $0.59 and its 200-day moving average is $1.06.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Citadel Advisors LLC bought a new position in iSpecimen during the 2nd quarter valued at $33,000. Vanguard Group Inc. increased its holdings in shares of iSpecimen by 166.3% in the 3rd quarter. Vanguard Group Inc. now owns 163,703 shares of the company’s stock worth $270,000 after acquiring an additional 102,241 shares during the period. Jane Street Group LLC acquired a new stake in shares of iSpecimen in the 1st quarter worth about $56,000. Finally, BlackRock Inc. increased its holdings in shares of iSpecimen by 903.6% in the 1st quarter. BlackRock Inc. now owns 71,175 shares of the company’s stock worth $382,000 after acquiring an additional 64,083 shares during the period. 4.61% of the stock is currently owned by institutional investors.

iSpecimen Company Profile

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations.